02/04/2026
Animal research helped make ALS treatments possible. “Until NAMs are fully validated with benchmarks that ensure their accuracy, reliability and relevance, we must also consider the ethical value of developing drugs for patients that are based on the best available science — a combination of animal research and NAMs,” FBR’s president wrote in a letter to the edit in the Los Angeles Times today.
Read the letter:
'According to the U.S. Government Accountability Office’s May 2025 report on the state of organ-on-a-chip technology, New Approach Methods (or NAMs) are playing an increasingly important role in drug development, but they lack established benchmarks,' writes an L.A. Times reader.